Trial Information

Summary: Brain Tumor [Glioblastoma Multiforme (GBM)] - Adults

People with GBM are asked to participate in a research study being conducted by Mount Sinai School of Medicine.

You may be eligible to participate in this study if you:

• Are between the ages of 18 and 70 years
• Are newly diagnosed with a brain tumor (Gliablastoma multifore - GBM) and have not had surgery

You may not participate in this study if you:

• Have an implantation of Gliadel® wafers at surgery
• Have been diagnosed with HIV, Hepatitis B or C
• Have a history of prior malignancy except for adequately treated basal cell or squamous cell skin cancer or in situ cervical cancer
• Have a history of autoimmune disease such as rheumatoid arthritis, Lupus (SLE), Multiple Sclerosis, Scleroderma, polymyositis-dermatomyositis, juvenile onset insulin dependent diabetes, or vasculitis
• Have had any previous cytotoxic drug therapies, excluding corticosteroids and temozolomide along with radiation therapy
• Have an acute viral, bacterial, or fungal infection that requires specific therapy including uncontrolled infection such as STD, herpes, scrofula, malaria, etc.
• Have a fever greater than or equal to 101.5°F
• Have an unstable or recurrent medical condition such as unstable angina, uncontrolled arrythmias, Crohn’s Disease, ulcerative colitis, etc.
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 30 days

If you would like to learn more about participating in this study, please send an e-mail message using the form below.